Sibel İBA YILMAZ, Serpil EROL, Ahmet ÖZBEK, Mehmet PARLAK

Distribution of viral genotypes and extrahepatic manifestations in patients with chronic hepatitis C in Eastern Turkey

To investigate the distribution of viral genotypes, the extrahepatic manifestations, and the relationship between genotypes and extrahepatic manifestations in patients with chronic hepatitis C. Materials and methods: The study included 62 treatment-naive patients with chronic hepatitis C infection. Genotype determination was performed by DNA sequencing analysis. To investigate extrahepatic manifestations, the patients' data, recorded prospectively during the pretreatment period, were analyzed. Results: Genotype determination was successful in 74.2% of the cases. All patients were infected with hepatitis C virus (HCV) genotype 1b. At least 1 extrahepatic manifestation was identified in 37.1% of the patients. The most frequent clinical manifestations were type II diabetes mellitus (8.1%) and arthralgia or arthritis (8.0%). There was no relationship between extrahepatic manifestations and fibrosis or transaminase levels, but female sex and advanced age were risk factors. Because all patients were infected with the same genotype, the relationship between extrahepatic manifestations and genotype could not be examined. Conclusion: HCV genotype 1b is predominant in patients with chronic hepatitis C in the Eastern Anatolian Region of Turkey. In total, 37.1% of the patients had at least 1 extrahepatic manifestation. Female sex and advanced age were risk factors for having extrahepatic manifestations.

Anahtar Kelimeler:

Chronic hepatitis, hepatitis C virus, genotypes, extrahepatic manifestations

Distribution of viral genotypes and extrahepatic manifestations in patients with chronic hepatitis C in Eastern Turkey

Keywords:

Chronic hepatitis, hepatitis C virus, genotypes, extrahepatic manifestations,

PDF

___

Baldo V, Baldovin T, Trivello R, Floreani A. Epidemiology of HCV infection. Curr Pharm Des 2008; 14: 1646–1654.
Ural O, Arslan U, Fındık D. The distribution of hepatitis C virus genotype in the Konya region, Turkey. İnfeksiyon Dergisi 2007; 21: 175–181 (in Turkish with an abstract in English).
Noto H, Raskin P. Hepatitis C infections and diabetes. J Diabetes Complications 2006; 2: 96–105.
Erol S, Sağlam L, Özbek A, Kadanalı A. Hepatitis C infection and chronic obstructive pulmonary disease. Hepatitis Monthly 2009; 9: 39–44.
Giannitti C, Morozzi G, D’Alfonso S, Bellisai F, Galeazzi M. Viral genotype and HLA class 2 alleles influence on extra- hepatic manifestations of chronic HCV infection. Reumatismo 2008; 60: 192–198.
Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben
Yahia MB, André C, Voisin MC, Intrator L, Zafrani ES, Duval J, et al. Extra-hepatic immunologic manifestations in chronic hepatitis C and hepatitis C serotypes. Ann Intern Med 1995; 122: 169–173.
Kendal Y, Değertekin H, Akkız H. HCV genotypes HCV related chronic hepatitis in Southeast Anatolia. Turk J Gastroenterol 1999; 10: 249–252.
Sönmez E, Taşyaran MA, Kızılkaya N, Korkut H, Tombul Z, Akçam Z. Yılmaz Ş, Köksal F, Leblebicioğlu H. The distribution of hepatitis C virus (HCV) genotypes in 59 HCV infected patients: a multicenter study. Flora 1996; 2: 92–95 (in Turkish with an abstract in English).
Bozdayı G, Rota S, Verdi H, Derici Ü, Sindel Ş, Bali M, Başay T. Investigation of the presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotypes. Mikrobiyol Bul 2002; 36: 291–294 (in Turkish with an abstract in English).
Şanlıdağ T, Akçalı S, Özbakkaloğlu B, Ertekin D, Akduman E. Distribution of Hepatitis C virus genotypes in Manisa region, Turkey. Mikrobiyol Bul 2009; 43: 613–618 (in Turkish with an abstract in English).
Altuglu I, Soyler I, Ozacar T, Erensoy S. Distribution of hepatitis
C virus genotypes in patient with chronic hepatitis C infection in Western Turkey. Int J Infect Dis 2008; 12: 239–244.
Küçüköztaş MF, Özgüneş N, Yazıcı S. Genotypes with HCV- RNA and alanine aminotransferase levels in chronic hepatitis C patients. Mikrobiyol Bul 2010; 44: 111–115 (in Turkish with an abstract in English).
Coşkun Y, Sayan M, Helvacı S, Dilek K, Mıstık R. Hepatitis C virus genotyping by using restriction fragment length polymorphism (RFLP) in anti-HCV positive hemodialysis patients and renal transplant recipients. Viral Hepatit Dergisi 2005; 1: 28–33 (in Turkish with an abstract in English).
CM Lee, CH Hung, SN Lu, C CS. Hepatitis C virus genotypes: clinical relevance and therapeutic implications. Chang Gung Med J 2008; 31: 16–24.
Altindis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S. Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. World J Gastroenterol 2006; 12: 6792–6796.
Liakina V, Speicene D, Irnius A, Naraskeviciene J, Barakauskiene A, Semuchiniene T. Prevalence of cryoglobulinaemia in patients with chronic HCV infection. Med Sci Monit 2002; 8: 31–36.
Donada C, Crucitti A, Donadon V, Tommasi L, Zanette G,
Crovatto M, Santini GF, Chemello L, Alberti A. Systemic manifestations and liver disease in patients with chronic hepatitis C type 2 or type 3 mixed cryoglobulinaemia. J Viral Hepatol 1998; 5: 179–185.
Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova
AP, Hadjiev EA, Dikova RP, Vukov MI, Tchernev KG. Chronic hepatitis C virus infection: Prevalence of extra-hepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J Gastroenterol 2007; 13: 6518–6528.
Soylu S, Gül U, Kiliç A. Cutaneous manifestations in patients
positive for anti-hepatitis C virus antibodies. Acta Derm Venerol 2007; 87: 49–53.
Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette
JC, Opolon P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42: 2204–2212.
Ejaz A, Ahmed R, Fazal I, Tahir M. Frequency of various cutaneous disorders in chronic hepatitis C virus infection. J Pak Assoc Derma 2010; 20: 10–14.
Seçkin Y, Karıncaoğlu M, Cömert M, Ateş F, Yiğit PI, Yıldırım O, Toktaş H. Prevalence of autoantibody in patients with chronic hepatitis B and C. Cumhuriyet Med J 2009; 31: 388–392 (in Turkish with an abstract in English).
Kırış S, Direşkendi H, Özener Ç, Akoglu E. Cryoglobulinemia prevalence and relation with HCV infection in chronic hemodialysis patients. Turkish Nephrology Dialysis and Transplantation Journal 1996; 3: 110–114 (in Turkish with an abstract in English).
Kadiroğlu AK, Göral V, Şit D, Çelik M, Yılmaz ME. The evaluation of the prevalence of extrahepatic findings in chronic hepatitis-C virus infection. Türkiye Klinikleri J Med Sci 2005; 25: 621–626.
Chia SC, Bergasa NV, Kleiner DE, Goodman Z, Hoofnagle JH,
Di Bisceglie AM. Pruritus as a presenting symptom of chronic hepatitis C. Dig Dis Sci 1998; 43: 2177–2183.
Dega H, Frances C, Dupin N, Lebre C, Simantov A, Callot C. Pruritus and the hepatitis C virus. The MULTIVIRC Unit. Ann Dermatol Venereol 1998; 125: 9–12.
Erol S, Çapoğlu İ, Yazgı H, Yılmaz Ö, Kadanalı A. Hepatitis C virus infection in the patients with type 2 diabetes mellitus. Flora 2003; 4: 297–301 (in Turkish with an abstract in English).
Naing C, Mak JW, Ahmed SI, Maung M. Relationship between
hepatitis C virus infection and type 2 diabetes mellitus: meta- analysis. World J Gastroenterol 2012; 18: 1642–1651.
Aydeniz A, Namiduru M, Karaoğlan I, Altındağ O, Yağız
E, Gürsoy S. Rheumatic manifestations of hepatitis B or C and their association with viral load and fibrosis of the liver. Rheumatol Int 2010; 30: 515–517.
Dieperink E, Willenbring M, Ho BS. Neuropsychiatric
symptoms associated hepatitis C and interferon alpha. Am J Psychiatry 2000; 157: 867–876.
Altındiş M, Orman A, Ünlü M, Kırlangıç Y. Hepatitis C Virus infection incidences in patients with chronic obstructive pulmonary disease. Viral Hepatit Dergisi 2004; 9: 76–81 (in Turkish with an abstract in English).
Cesur S, Akın K, Albayrak F, Birengel S, Kurt H, Balık İ. Prevalence of extra-hepatic illnesses in patients with chronic hepatitis B and hepatitis C: retrospective study of 435 patients. Mikrobiyol Bul 2003; 37: 187–193 (in Turkish with an abstract in English).
Himoto T, Masaki T. Extra-hepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol 2012; 2012: 871401.
Ferri C, La Civita L, Zigneko AL, Pasero G. Viruses and cancers:
possible role of hepatitis C virus. Eur J Clin Invest 1997; 27: 711–718.
Yenice N, Güllük F, Arıcan N, Türkmen S. HCV prevalence in Hogkin and non-Hodgkin lymphoma cases. Turk J Gastroenterol 2003; 14: 173–176.